Aspirin Clinical Trials

8 recruiting

Aspirin Trials at a Glance

12 actively recruiting trials for aspirin are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Milan, Busan, and Caen. Lead sponsors running aspirin studies include OCEAN-SHD Study Group, Consorzio Mario Negri Sud, and Centre Hospitalier Intercommunal Creteil.

Browse aspirin trials by phase

Treatments under study

About Aspirin Clinical Trials

Looking for clinical trials for Aspirin? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Aspirin trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Aspirin clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Arterial Occlusive DiseasesCardiovascular DiseasesCoronary Disease+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS576 enrolled1 locationNCT06535568
Recruiting
Phase 1

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

Diabetes Mellitus, Type 2Type 2 DiabetesAspirin+2 more
Montreal Heart Institute30 enrolled1 locationNCT05702463
Recruiting
Phase 3

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Pre-EclampsiaIntrauterine Growth RestrictionAspirin+3 more
Centre Hospitalier Intercommunal Creteil500 enrolled20 locationsNCT04356326
Recruiting
Phase 4

Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure

Left Atrial Appendage ClosureAspirinNonvalvular Atrial Fibrillation+2 more
OCEAN-SHD Study Group500 enrolled21 locationsNCT07125417
Recruiting

Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)

ThrombosisBlood Coagulation DisorderPlatelet Thrombus+2 more
Scientific Institute San Raffaele60 enrolled1 locationNCT03255928
Recruiting

Immunomodulation During Pregnancy

Pregnancy ComplicationsAspirinImmunology
Unidade Local de Saúde de Coimbra, EPE30 enrolled1 locationNCT06882850
Recruiting
Phase 3

Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

Gastric CancerAspirin
National Cancer Center, Korea1,700 enrolled10 locationsNCT04214990
Recruiting
Phase 4

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

AspirinAortic StenosisTAVI(Transcatheter Aortic Valve Implantation)+2 more
OCEAN-SHD Study Group400 enrolled1 locationNCT06007222
Recruiting
Phase 2

Mechanisms of Dupilumab in AERD

Aspirin-exacerbated Respiratory Disease
Scripps Clinic16 enrolled1 locationNCT05031455
Recruiting
Not Applicable

The Effect of Aspirin on Recurrent Acute Pancreatitis

PreventionRecurrent Acute PancreatitisAspirin
Air Force Military Medical University, China23 enrolled1 locationNCT06185621
Recruiting
Phase 4

Treating Aspirin Resistance with GuidEd Therapy in Diabetes (TARGET-Diabetes) Study

aspirin resistance
RMIT University400 enrolled1 locationACTRN12611001132932
Recruiting
Phase 3

A large-scale trial testing the intensity of CYTOreductive therapy to prevent cardiovascular events In patients with Polycythemia Vera (PV)

To assess the benefit/risk profile of cytoreductive therapy with phlebotomy and/or hydroxyurea (HU) aimed at maintaining hematocrit (HCT) < 45% Vs. maintaining HCT in the range of 45-50% in patients with PV treated at the best of recommended therapies (e.g., low dose of aspirin when indicated and adequated control of standard cardiovascular risk factors)
Consorzio Mario Negri Sud1,000 enrolled1 locationACTRN12609000046202